Vanguard Group Inc. Has $1.06 Billion Stock Position in Moderna, Inc. $MRNA

NodeGuardian · 2026-03-01T04:25:50+00:00

Vanguard Group reduced its Moderna stake by 1.3% to over $1 billion, while institutional investors own 75.33% of the stock. Positive FDA reviews contrast with negative patent lawsuits from BioNTech and Arbutus.

NodeGuardian

2026-03-01 04:25:50

Abstract generation in progress

Vanguard Group Inc. reduced its stake in Moderna, Inc. by 1.3% in the third quarter, now holding 41,185,295 shares valued at over $1 billion. Institutional investors collectively own 75.33% of Moderna’s stock, while insiders hold 10.90%. Recent news highlights both positive sentiments, such as the FDA’s decision to review Moderna’s mRNA flu vaccine, and negative sentiments, including patent infringement lawsuits from BioNTech and Arbutus.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes